EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
What Changes at Scale, and How Do You Know?
A pharmaceutical process that performs reliably on a few grams of material can behave very differently at pilot or commercial scale The temperature setpoint that worked on the bench the mixing time that delivered a uniform blend the feed rate that kept a reaction on track none of these is guaranteed to mean the same thing in larger equipment When that difference goes...
Advisory Board
KNOWLEDGE BANK
-
Articles
7 B2B Pharma Display Ad Strategies That Actually Drive Leads (2026 Guide)
Theres a quiet frustration most pharma marketers dont say out loud display ads should work better than they do Budgets go in Impressions look fine CTRs are acceptable And yet pipeline barely moves
European Pharmaceutical Legal Frameworks: Compliance, Legislation and Regulatory Obligations
If youve ever opened the EUs pharmaceutical rulebook and felt your eyes glaze over youre not alone Directives regulations guidelines delegated acts it can feel like reading a legal maze with no exit sign
AI Governance in Pharma: Managing Trust, Transparency, and Regulatory Expectations
Most large pharmaceutical organisations no longer have an AI strategy problem They have an AI accountability problem Models now sit inside pharmacovigilance case intake deviation triage visual inspection trial feasibility medical information and commercial targeting deployed by different functions on different platforms under different assumptions about who signs
Revolutionizing Healthcare with Innovative Therapeutics
Revolutionizing healthcare with innovative therapeutics involves the development and application of groundbreaking treatments and approaches that significantly improve patient outcomes reduce costs and enhance overall healthcare effectiveness
How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights
The pharmaceutical industry operates within a complex regulatory framework aimed at ensuring the safety efficacy and quality of medicinal products
Overcoming Challenges in Cell and Gene Therapy Manufacturing
Europe authorised its first chimeric antigen receptor CAR Tcell therapies in Eight years on the science has settled far more convincingly than the supply chain Between October and June the European Medicines
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
European Pharmaceutical Legal Frameworks: Compliance, Legislation and Regulatory Obligations
Kate Williamson
EU pharmaceutical law governs how medicines are authorized, manufactured, distributed and monitored across Europe. This guide explains key legislation, including Directive 2001/83/EC and the Clinical...
-
2
AI Governance in Pharma: Managing Trust, Transparency, and Regulatory Expectations
Lakshmi
Artificial intelligence has moved from pharma's innovation agenda into its compliance perimeter. Europe's rewritten AI timeline, the first GMP annex written specifically for AI, and the first...
-
3
Revolutionizing Healthcare with Innovative Therapeutics
Kate Williamson
Revolutionizing healthcare demands innovative therapeutics, including precision medicine, immunotherapy, gene therapy, nanomedicine, telemedicine, AI in drug discovery, regenerative medicine, digital...
-
4
How Pharmacoepidemiology Drives Clinical Research: Exploring Trends and Insights
Kate Williamson
This paper delves into how pharmacoepidemiology influences clinical research through innovative pharmaceutical packaging. It highlights regulatory challenges such as tamper-proofing, child-resistant p...
-
5
Overcoming Challenges in Cell and Gene Therapy Manufacturing
Lakshmi
Cell and gene therapies now reach only a minority of eligible European patients, and the reason is rarely scientific. Manufacturing slots, release testing, vector supply and fragmented national assess...
press releases Read more...
Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development
Cancer Research UK and Dewpoint Therapeutics today announced a collaboration and licence agreement to advance DPTX a potential firstinclass small molecule modulator of MYC condensates into clinical development
Instem and Histofy Launch Provantis® Compose, Accelerating Nonclinical Study Reporting Through AI-Assisted Automation and Expert Oversight
Instem a leading provider of software for life sciences research and regulatory operations across preclinical and clinical RD today announced a strategic partnership with Histofy to launch Provantis Compose a powerful new module designed to automate and accelerate the creation of final study reports...
Rosemont Pharmaceuticals to acquire Aytu BioPharma to accelerate US expansion
Rosemont Pharmaceuticals Holdings Inc Rosemont a global specialty pharmaceutical company focused on designing and delivering medicines around patients needs today announced that it has entered into a definitive merger agreement
Asimov and Emergent Biosolutions Announce Cell Line Development Partnership to Advance Novel Antibodies Against Ebola
Asimov the company building an AInative synthetic biology platform to advance therapeutic development and Emergent Biosolutions NYSE EBS a leading global public health company today announced a cell line development partnership
Events Read more...
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
25 - 25
Nov 2026What’s Next for Pharma Marketing in 2027
Landesmuseum Zürich, Zurich, S...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
01 - 03
Dec 2026Pharmaceutical Launch Excellence Summit
Novotel Amsterdam City, Nether...
01 - 03
Dec 202610th Antifibrotic Drug Development
Boston, MA at the Hotel Common...
02 - 04
Dec 2026Genome Informatics 2026
Wellcome Genome Campus, UK
03 - 04
Dec 2026Pharmacy and Pharmaceutical Conference
Madrid, Spain
LATEST NEWS Read more...
Erasca Partners with Bristol Myers Squibb to Study ERAS-0015 Combination Therapy for Pancreatic Cancer
Erasca Inc a clinicalstage precision oncology company focused on developing treatments for cancers driven by the RASMAPK signalling pathway has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb BMS
Libtayo Receives EU Approval for Extended Dosing and Shorter Infusion Times Across Six Cancer Indications
Regeneron Pharmaceuticals has received European Commission EC approval for an alternative dosing schedule for Libtayo cemiplimab across all six of its approved indications for skin lung and cervical cancers in the European Union EU
FDA approves Roche’s Wilserdly for ER-positive, ESR1-mutated advanced breast cancer
Roche has received approval from the US Food and Drug Administration FDA for Wilserdly giredestrant in combination with everolimus to treat adults with oestrogen receptor ERpositive human epidermal growth factor receptor HERnegative ESRmutated locally advanced or metastatic breast cancer
European Commission approves Revolution Medicines’ RASONQUE for metastatic pancreatic cancer
Revolution Medicines has received European Commission EC approval for RASONQUE daraxonrasib to treat adults with metastatic pancreatic adenocarcinoma who have received at least one previous systemic therapy The medicine is taken once daily as an oral tablet and is approved for patients with or witho...
Immuneering and Astellas to Evaluate Combination Treatments for CLDN18.2-Expressing Pancreatic Cancer
Immuneering Corporation Nasdaq IMRX has entered into a clinical trial collaboration and supply agreement with Astellas Pharma Global Development Inc a subsidiary of Astellas Pharma Inc TSE to evaluate combination treatments for patients with pancreatic cancer whose tumours express CLDN
Takeda Launches ORZEYFUL (Oveporexton), the First Orexin Agonist for Narcolepsy Type 1, in the US
Takeda TSE NYSE TAK has announced the US launch of ORZEYFUL oveporexton CIV now available by prescription for adults with narcolepsy type NT also known as narcolepsy with cataplexy The medicine is the first and only orexin agonist available for this condition








